Merck 1Q Revenues: $10.8 billion, (+8%) 1Q Earnings: $2.9 billion (earnings were $736 million 1Q18) Comments: Growth in the quarter was driven by Oncology and Vaccines. International sales represented 58% of total sales in the quarter led by China, with $725 million in sales, up 58%. Keytruda sales were up 55% to $2.3 billion. Januvia sales were $1.4 billion, down 5%. Gardasil sales were up 27% to $838 million. Proquad, M-M-R II and Varivax sales were $496 million, up 27%. Bridion sales were ...